FDA withdraws Cipla Pharma license cancellation after Bombay HC criticism
FDA withdrew its order to cancel Cipla Pharma’s license after a Bombay HC criticized the action as “going overboard.”
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.